Intermittent Fasting in Hypertriglyceridemic Overweight or Obese Subjects

Status Completed

Clinical Trial Summary

some studies have shown similar effects of intermittent fasting and continuous caloric restriction on body weight and plasma lipid profile, but there is still a wide controversy. Therefore,due to limited human studies and the lack of a study on hypertriglyceridemic patients, the present study aimed to determine the effects of using low-calorie diets in comparison with continuous caloric restriction on weight loss and plasma lipid profile in obese or overweight hypertriglyceridemic patients.

Clinical Trial Description

a randomized clinical trial will be conducted in National Nutrition and Food Technology Research Institute, Tehran, Iran. after the review of inclusion and exclusion criteria, a written consent form will be completed. the participants will be 90 hypertriglyceridemic patients aged between 18-60. half of the participants will be under intermittent low-calorie diet which they will have 3 alternate days in the week eating only 30% of their total energy requirement and on the other days of the week they receive a total calorie of 100% of their energy requirement , therefore there will be a total of -210% TEE reduction in their received energy in the week. the other group will be under continuous calorie restriction meaning on all the days of the week they will be eating 70% of their total energy requirement resulting in a total of -210% TEE reduction in their received energy in the week. both groups will receive 3 consultation sessions with a nutritionist, also to prevent any deficiency, multi-vitamin-mineral supplements will be given to both groups participants. ;

Study Design

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT04143971
Study type	Interventional
Source	Shahid Beheshti University
Contact
Status	Completed
Phase	N/A
Start date	December 2, 2019
Completion date	May 20, 2020

View Details

See also
Status	Clinical Trial	Phase
Completed	`NCT03929198` - Translation of Pritikin Program to the Community	N/A
Completed	`NCT02250105` - Trial of ARI-3037MO to Reduce Triglyceride Levels in Adults With Severe (≥500 mg/dl) Hypertriglyceridemia	Phase 2
Completed	`NCT02859129` - Study to Evaluate the 2-Way Interaction Between Multiple Doses of Epanova™ and a Single Dose of Rosuvastatin (Crestor®)	Phase 1
Completed	`NCT01455844` - TRIal For Efficacy of Capre on hyperTriglyceridemiA	Phase 2
Completed	`NCT01437930` - Intervention With n-3 Polyunsaturated Fatty Acids (PUFA)-Supplemented Products in Moderate Hypertriglyceridemic Patients	N/A
Completed	`NCT00959842` - Effects of Lovaza on Lipoprotein Composition and Function in Mild Hypertriglyceridemia	Phase 1/Phase 2
Completed	`NCT01010399` - Boosted Lexiva With Lovaza Adjunctive Therapy in Hypertriglyceridemic, HIV-Infected Subjects	Phase 4
Completed	`NCT00519714` - A Study to Evaluate the Lipid Regulating Effects of 1-Methylnicotinamide (1-MNA)	Phase 2/Phase 3
Recruiting	`NCT00186537` - Comparing Tricor, Avandia, or Weight Loss to Lower Cardiovascular Risk Factors in People With High Triglycerides.	N/A
Completed	`NCT00246402` - Acipimox to Improve Hyperlipidemia and Insulin Sensitivity Associated With HIV	N/A
Completed	`NCT06020950` - Chia Seeds Consumption in Hypertriglyceridemia	N/A
Completed	`NCT02354976` - A Double-blind Randomized Placebo-controlled Study Comparing Epanova and Fenofibrate on Liver Fat in Overweight Subjects.	Phase 2
Completed	`NCT04966494` - Impact of Beans and Oats Snack Bar on Hypertriglyceridemic Women	N/A
Completed	`NCT04650152` - Study to Assess Tricor Therapy Effectiveness in Patients With Metabolic Syndrome (TRISTAN)
Completed	`NCT04630366` - A Phase 1, First Time in Humans Study of NST-1024	Phase 1
Completed	`NCT03693131` - Efficacy of MND-2119 in Participants With Hypertriglyceridemia	Phase 3
Completed	`NCT02868177` - Effect of Totum-63, Active Ingredient of Valedia, on Glucose and Lipid Homeostasis on Subjects With Prediabetes	Phase 2/Phase 3
Completed	`NCT04756180` - An Efficacy and Safety Study of Omega-3-acid Ethyl Ester in Chinese Subjects With Hypertriglyceridemia.	Phase 3
Completed	`NCT01968720` - Pilot Study To Assess CAT-2003 in Patients With Severe Hypertriglyceridemia	Phase 2
Completed	`NCT01462877` - A Study to Evaluate Fenofibrate Combination With Statin in Chinese Patients With Dyslipidemic	Phase 4